Private Market View

LifeMine

Drug Discovery

Last price · $/share
Implied valuation
Total raised
$175.0M
Last round
Later Stage VC (Series C)
Mar 2022
Valuation — not yet established

No valuation for LifeMine is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($175.0M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·Watchlist + deal alerts for LifeMine
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Mar 2022Later Stage VC (Series C)$175.0M

How LifeMine's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For LifeMine, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

How much has LifeMine raised?
LifeMine has raised $175.0M in total funding across 1 recorded rounds.
When did LifeMine last raise?
LifeMine last raised in Mar 2022 (Later Stage VC (Series C)), raising $175.0M.